ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
Código da empresaASPI
Nome da EmpresaASP Isotopes Inc
Data de listagemNov 10, 2022
CEOMr. Paul Elliot Mann
Número de funcionários136
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 10
Endereço601 Pennsylvania Avenue Nw
CidadeWASHINGTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal20004
Telefone12027562245
Sitehttps://aspisotopes.com/
Código da empresaASPI
Data de listagemNov 10, 2022
CEOMr. Paul Elliot Mann
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados